Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Alterity Therapeutics Limited

Suite 2 Level 15, 500 Collins Street, 3000

About the sponsor

Alterity Therapeutics Limited focuses on clinical research in Multiple System Atrophy, a progressive neurodegenerative disorder affecting movement and autonomic function.

  • Multiple System Atrophy
  • Neurodegeneration
  • Autonomic dysfunction
  • Motor impairment

The sponsor’s research activity is centered on treatment options for patients living with this rare neurological condition.

About Specializations

Alterity Therapeutics Limited runs clinical trials in conditions such as Multiple system atrophy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Multiple system atrophy

Recruiting

Open-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:5,7-DICHLORO-2-((ETHYLAMINO)METHYL)-8-HYDROXY-3-METHYLQUINAZOLIN-4(3H)-ONE METHANESULFONATE
  • Sponsor:Alterity Therapeutics Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.